Pricing

XTL Biopharmaceuticals Ltd ADR (XTLB)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Shlomo S. Shalev
Employees:
8
XTL BIOPHARMACEUTICALS LTD, C/O ALSTON & BIRD LLP, 90 PARK AVENUE, NEW YORK, NY, 10016
972 9 955 7080
    Formally known as:
  • XTL Biopharmaceuticals Ltd.
  • XTL Biopharmaceuticals Ltd.
  • XTL BIOPHARMACEUTICALS LTD. NEW
  • XTL BIOPHARMACEUTICALS LTD. NEW
Stock Split History
DateRatio
2012-10-04 1:10
2017-02-10 1:5
The company's lead drug candidate is hCDR1, a Phase II-ready asset for the treatment of systemic lupus erythematosus and Sjogren's syndrome. XTL Biopharmaceuticals Ltd. is headquartered in Ramat Gan, Israel.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available